187 related articles for article (PubMed ID: 11219330)
1. The relationship between psychiatric diseases and insomnia.
Roth T
Int J Clin Pract Suppl; 2001 Jan; (116):3-8. PubMed ID: 11219330
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of zaleplon at peak plasma levels.
Mangano RM
Int J Clin Pract Suppl; 2001 Jan; (116):9-13. PubMed ID: 11219331
[TBL] [Abstract][Full Text] [Related]
3. Benefit-risk assessment of zaleplon in the treatment of insomnia.
Barbera J; Shapiro C
Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
[TBL] [Abstract][Full Text] [Related]
4. Sleep interventions for the treatment of depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2011 Jan; 49(1):17-20. PubMed ID: 21175118
[TBL] [Abstract][Full Text] [Related]
5. A psychiatric perspective on insomnia.
McCall WV
J Clin Psychiatry; 2001; 62 Suppl 10():27-32. PubMed ID: 11388587
[TBL] [Abstract][Full Text] [Related]
6. Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.
Rosenberg RP
Ann Clin Psychiatry; 2006; 18(1):49-56. PubMed ID: 16517453
[TBL] [Abstract][Full Text] [Related]
7. Main neuroendocrine features and therapy in primary sleep troubles.
Amihăesei IC; Mungiu OC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
[TBL] [Abstract][Full Text] [Related]
8. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
9. Management of insomnia--the role of zaleplon.
Richardson GS; Roth T; Kramer JA
MedGenMed; 2002 Mar; 4(1):9. PubMed ID: 11965211
[TBL] [Abstract][Full Text] [Related]
10. Safety of zaleplon in the treatment of insomnia.
Israel AG; Kramer JA
Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
[TBL] [Abstract][Full Text] [Related]
11. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
[TBL] [Abstract][Full Text] [Related]
12. Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?
Srinivasan V; Brzezinski A; Pandi-Perumal SR; Spence DW; Cardinali DP; Brown GM
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):913-23. PubMed ID: 21453740
[TBL] [Abstract][Full Text] [Related]
13. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
Ansseau M
Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
[TBL] [Abstract][Full Text] [Related]
14. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Weitzel KW; Wickman JM; Augustin SG; Strom JG
Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
[TBL] [Abstract][Full Text] [Related]
15. Zaleplon for insomnia.
Med Lett Drugs Ther; 1999 Oct; 41(1063):93-4. PubMed ID: 10535052
[No Abstract] [Full Text] [Related]
16. Implications of hypnotic flexibility on patterns of clinical use.
Lader MH
Int J Clin Pract Suppl; 2001 Jan; (116):14-9. PubMed ID: 11219327
[TBL] [Abstract][Full Text] [Related]
17. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L
Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888
[TBL] [Abstract][Full Text] [Related]
18. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Heydorn WE
Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
[TBL] [Abstract][Full Text] [Related]
19. Treatment of insomnia with zaleplon, a novel sleep medication.
Doghramji PP
Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
[TBL] [Abstract][Full Text] [Related]
20. New insomnia drug. Are there any medications to treat insomnia that won't leave me feeling groggy the next day?
Johns Hopkins Med Lett Health After 50; 2000 Mar; 12(1):8. PubMed ID: 10740445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
